Neuland Laboratories Ltd Half Yearly Results

Gross Sales

726.39

750.45

777.84

780.74

676.32

Excise Duty

0

0

0

0

0

Net Sales

726.39

750.45

777.84

780.74

676.32

Other Operating Income

0

0

0

0

0

Other Income

67.15

29.77

7.46

5.09

9

Total Income

793.54

780.21

785.3

785.83

685.32

Total Expenditure

588.72

564.86

549.66

546.34

502.38

PBIDT

204.82

215.35

235.64

239.49

182.94

Interest

4.56

3.73

7.35

6.65

7.03

PBDT

200.26

211.62

228.29

232.85

175.9

Depreciation

33.19

32.35

31.61

28.09

26.81

Minority Interest Before NP

0

0

0

0

0

Tax

30.97

42.79

47.28

52.39

32.01

Deferred Tax

6.7

5.76

0.45

1.24

2

Reported Profit After Tax

129.39

130.72

148.95

151.13

115.09

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

129.39

130.72

148.95

151.13

115.09

Extra-ordinary Items

55.78

15.04

0

0

0

Adjusted Profit After Extra-ordinary item

73.61

115.68

148.95

151.13

115.09

EPS (Unit Curr.)

100.3

101.88

115.46

117.79

89.22

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.9

12.9

12.9

12.9

12.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.19

28.69

30.29

30.67

27.04

PBDTM(%)

-

-

-

-

-

PATM(%)

17.81

17.41

19.14

19.35

17.01